Home › Pulmonary Hypertension › Colorado › Denver
Pulmonary Hypertension clinical trials in Denver, CO
4 studies for Pulmonary Hypertension are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- National Jewish Health, Denver
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- National Jewish Hospital, Denver
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- National Jewish Health, Denver
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
RecruitingObservational study
- National Jewish Health, Denver
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Aurora, CO9 studies
- Phoenix, AZ9 studies
- Cincinnati, OH8 studies
- New York City, NY8 studies
- Indianapolis, IN8 studies
- Boston, MA8 studies
- Kansas City, KS8 studies
- Rochester, MN7 studies
- Charleston, SC7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer29 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma27 studies
- Colorectal Cancer23 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.